Stevanato Group S.p.A (STVN) Net Income towards Common Stockholders (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Net Income towards Common Stockholders came in at $0.12 in Q1 2026, up 11.3% year-on-year from $0.11 in Q1 2025, and down 100.0% on a QoQ basis from $55.4 million in Q4 2025.
Stevanato Group S.p.A (STVN) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Net Income towards Common Stockholders data on file, last reported at $0.12 in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 11.3% year-over-year to $0.12 in Q1 2026; TTM through Mar 2026 was $55.4 million, a 7.22% increase from a year earlier, with the FY2025 full-year figure at $162.8 million, up 29.34% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at $0.12, down from $55.4 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for STVN reached as high as $55.4 million in Q4 2025 and fell as low as $0.08 in Q1 2024.
- Historically, Net Income towards Common Stockholders has averaged $18.0 million across 5 years, with a median of $0.15 in 2025.
- Across the five-year window, Net Income towards Common Stockholders jumped 65.99% in 2022 and sank 100.0% in 2023, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at $49.4 million in 2022, then slipped by 1.41% to $48.7 million in 2023, then gained by 6.08% to $51.6 million in 2024, then rose by 7.22% to $55.4 million in 2025, then tumbled by 100.0% to $0.12 in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $0.12 in Q1 2026, $55.4 million in Q4 2025, and $0.15 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Stevanato Group S.p.A | 5.39 Bn | 5.25 Bn | 88.01 Mn | 0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.12 |
| Dec 31, 2025 | 55.36 Mn |
| Sep 30, 2025 | 0.15 |
| Jun 30, 2025 | 0.12 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 51.63 Mn |
| Sep 30, 2024 | 0.12 |
| Jun 30, 2024 | 0.09 |
| Mar 31, 2024 | 0.08 |
| Dec 31, 2023 | 48.67 Mn |
| Sep 30, 2023 | 0.15 |
| Jun 30, 2023 | 0.14 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 49.36 Mn |
| Sep 30, 2022 | 36.51 Mn |
| Jun 30, 2022 | 32.58 Mn |
| Mar 31, 2022 | 31.11 Mn |
| Dec 31, 2021 | 51.11 Mn |
| Sep 30, 2021 | 22.00 Mn |
| Jun 30, 2021 | 41.48 Mn |